Temsirolimus
Links shared publicly online about this topic
Temsirolimus with chemotherapy may serve as promising therapy for mesothelioma
news-medical.net — “A drug commonly used to treat kidney cancer may increase the effectiveness of chemotherapy for mesothelioma, according to a study published in the May issue of the Journal of Thoracic Oncology.” View full resource at news-medical.net
Most Recently Shared on May 2, 2011 at 8:04 am By:
News-Medical.Net Oncology and Health News
Oncology News: Temsirolimus with chemotherapy may serve as promising therapy for mesothelioma: A drug commonly u... http://bit.ly/iCLodz
ingentaconnect Sorafenib/sunitinib/temsirolimus: Various toxicities: 19 case rep...
ingentaconnect.com — “ingentaconnect Sorafenib/sunitinib/temsirolimus: Various toxicities: 19 case rep...” View full resource at ingentaconnect.com
Most Recently Shared on April 5, 2011 at 10:26 am By:
Sorafenib/sunitinib/temsirolimus: Various toxicities: 19 case reports: (Source: Reactions) http://bit.ly/eu4eeA
Renal cancer drug temsirolimus shows promise against mesothelioma
medicalxpress.com — “A drug commonly used to treat kidney cancer may increase the effectiveness of chemotherapy for mesothelioma, according to a study published in the May issue of the Journal of Thoracic Oncology.” View full resource at medicalxpress.com
Most Recently Shared on May 1, 2011 at 9:50 am By:
PhysOrg Health News Health News
Renal cancer drug temsirolimus shows promise against mesothelioma http://tw.medicalxpress.com/223446988
Clinical trial experience with temsirolimus in pat... [Semin Oncol. 2009] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on January 22, 2010 at 9:08 am By:
ACOR Kidney Cancer Health Organization
Clinical trial experience with temsirolimus in patients with advanced renal cell carcinoma. - http://bit.ly/7iCyCQ
[mTOR inhibitors: temsirolimus and everolimus in t... [Bull Cancer. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on May 21, 2010 at 9:11 am By:
ACOR Kidney Cancer Health Organization
[mTOR inhibitors: temsirolimus and everolimus in the treatment of renal cell carcinoma] - http://bit.ly/8X3RQN
Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial : The Lancet Oncology
thelancet.com — “Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial. By - Prof Sylvie Négrier MD, Gwe...” View full resource at thelancet.com
Most Recently Shared on June 11, 2011 at 1:05 pm By:
combination therapy for renal cancer hurdles http://t.co/AUyycoE
Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer - Full Text View - ClinicalTrials.gov
clinicaltrials.gov — “Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on May 28, 2011 at 4:45 pm By:
Paul Cacciatore Patient Advocate
Gyn Oncol Grp recruiting clear cell ovarian cancer patients for 1st line treatment w/temsirolimus + carbo + paclitaxel. http://dld.bz/ab589
Oncology Article | Metformin
mdlinx.com — “A phase I study of temsirolimus and metformin in advanced solid tumours” View full resource at mdlinx.com
Most Recently Shared on November 4, 2010 at 9:58 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A phase I study of temsirolimus and metformin in advanced solid tumours: Investigational New Drugs http://bit.ly/cVAJg9 #oncology
Oncology Article | Multiple Myeloma
mdlinx.com — “Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: A multicentre, phase 1/2, open-label, dose-escalation study” View full resource at mdlinx.com
Most Recently Shared on February 23, 2011 at 7:53 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple mye... http://bit.ly/f80mqf #oncology
Oncology Article | Lymphoma, Mantle-Cell
mdlinx.com — “Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: A phase 2 study” View full resource at mdlinx.com
Most Recently Shared on March 29, 2011 at 5:33 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: A phase 2 stu... http://bit.ly/h5M5DS #oncology
Oncology Article | Endometrial Neoplasms
mdlinx.com — “Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: A trial of the NCIC Clinical Trials Group” View full resource at mdlinx.com
Most Recently Shared on July 28, 2011 at 7:10 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: A trial of th... http://bit.ly/r2vXgu #oncology
Neoplasms on #MDlinx
mdlinx.com — “Neoplasms on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 21, 2010 at 4:11 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Combination of temsirolimus (CCI-779) with chemo-radiation in newly diagnosed GBM is associated with increas... http://bit.ly/c8tepd #neuro
Warning! | There might be a problem with the requested link
bit.ly — “Warning! | There might be a problem with the requested link” View full resource at bit.ly
Most Recently Shared on April 15, 2010 at 11:41 pm By:
Kidney Cancer Health Executive
Neoadjuvant temsirolimus effectiveness in downstaging advanced non-clear cell renal cell carcinoma http://bit.ly/bHahb5
Quality of life in patients with advanced renal ce... [Br J Cancer. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on June 10, 2010 at 9:08 am By:
ACOR Kidney Cancer Health Organization
Quality of life in patients with advanced renal cell carcinoma treated with temsirolimus or interferon-alpha. - http://bit.ly/9VpVSz
NICE rejects use of kidney cancer drugs | News | Nursing Times
nursingtimes.net — “NICE will not approve bevacizumab (Avastin), sorafenib (Nexavar) and temsirolimus to treat kidney cancer patients” View full resource at nursingtimes.net
Most Recently Shared on August 26, 2009 at 11:38 am By:
News: NICE rejects use of kidney cancer drugs http://bit.ly/w0dSs
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
News-Medical.Net
Stay up to date with the latest Oncology news and research via News-Medical.Net
-
Toxins OW
Organizing toxins and chemicals resources shared by health experts, advocates, and organizations into WisdomCards.
-
PhysOrg Health News
PhysOrg.com Health and Medicine News Stories
Advertisement
